Beretta Giangiacomo, Panseri Sara, Manzo Alessandra, Hamid Rufaida, Richards Adrian, Malacco Matteo
Department of Pharmaceutical Sciences, University of Milan, Milan, Italy.
Department of Veterinary Science and Public Health, University of Milan, Milan, Italy.
J Pharm Biomed Anal. 2014 Sep;98:144-52. doi: 10.1016/j.jpba.2014.05.017. Epub 2014 May 23.
In this study we have analysed the chemical composition of the extractable components from the elastomeric shells from n=27 explanted implants (n=16 patients), n=2 new PIP implants, and from explanted Eurosilicone and McGhan implants (n=2 for each brand). Empty elastomeric PIP shells (n=2) were also available for analysis. Prostheses were explanted between 2011 and 2012, after 3-11 years of implantation. Patients presented pre- and post-operation complications of different degrees. First we evaluated the micro-structural features of the shells by phase contrast microscopy, and compared the results with those obtained using attenuated total reflectance infrared spectroscopy (ATR-FT-IR), head space gas chromatography coupled to mass spectrometry (HS-GC-MS) and GC-MS in direct injection mode. The results of these studies confirm and explain the conclusion of previous international investigations that evidenced a linear decrease of rupture rate for prostheses implanted after 2006. The analytical identification of a series of UV sensitive radical photo-initiators (0.1%-0.2% w/w), belonging to the benzophenone family, in the shells of new and explanted prostheses produced after 2006 (associated with a strong smell absent in those produced earlier), in parallel to (ii) the removal of the anti bleed barrier from their manufacturing procedure (introduced after 2001), strongly suggested that from 2007, the PIP company used a polymerisation process different from that declared, probably as a consequence of the first reports of rupture problems. In addition, the HS-GC-MS experiments demonstrated that at body temperature the diffusivity of low molecular weight (LMW) silicones present in the PIP filler silicone is significantly higher than that of LMW silicones in an approved implant.
在本研究中,我们分析了从27个取出的植入物(16名患者)的弹性体外壳、2个新的PIP植入物以及取出的Eurosilicone和McGhan植入物(每个品牌2个)中可提取成分的化学组成。还提供了2个空的弹性体PIP外壳用于分析。假体在植入3至11年后于2011年至2012年取出。患者出现了不同程度的术前和术后并发症。首先,我们通过相差显微镜评估了外壳的微观结构特征,并将结果与使用衰减全反射红外光谱(ATR-FT-IR)、顶空气相色谱-质谱联用(HS-GC-MS)和直接进样模式的GC-MS获得的结果进行了比较。这些研究结果证实并解释了先前国际调查的结论,即2006年后植入的假体破裂率呈线性下降。在2006年后生产的新假体和取出的假体外壳中分析鉴定出一系列属于二苯甲酮家族的对紫外线敏感的自由基光引发剂(0.1%-0.2% w/w)(与早期生产的假体中没有的强烈气味相关),与此同时,在其制造过程中取消了防渗漏屏障(2001年后引入),这强烈表明从2007年起,PIP公司使用了与宣称不同的聚合工艺,这可能是首次出现破裂问题报告的结果。此外,HS-GC-MS实验表明,在体温下,PIP填充硅酮中存在的低分子量(LMW)硅酮的扩散率明显高于经批准的植入物中的LMW硅酮。